ArticleJournal of the American Academy of Dermatology2014
Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.
5 registry-linked trialsOpen access · greenAbstract read
In one paragraph
Article in Journal of the American Academy of Dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 425 papers, 10 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
425citing papers in PubMed, 10 pooled it
73.7field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis Therapy
A Randomised, Double-blind, Placebo-controlled, Phase 2b Study to Assess the Efficacy and Safety of Orally Administered DS107 in Patients With Moderate to Severe Atopic Dermatitis
The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis
Proof of Concept Investigation of the Steroid-reducing Effects of Crisaborole in Children
Short-pulse and Ultra-Short Pulse ND: YAG 1064 Lasers for Stasis Dermatitis Secondary to Chronic Venous Hypertension Treatment: the SUPERSTAR Trial
Who cites it
425 citing papers in PubMed, 10 syntheses or guidelines pooled it, 1,176 citations in OpenAlex.
- Skin barrier-related genes in childhood atopic dermatitis, asthma, and allergy: A systematic review and meta-analysis.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026Pooled it
- Efficacy and safety of tapinarof in atopic dermatitis: a frequentist and bayesian meta-analysis of randomized controlled trials.Inflammopharmacology · 2026Pooled it
- Leukotriene Receptor Antagonists for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-analysis.Acta dermato-venereologica · 2025Pooled it
- Effectiveness and safety of topical phosphodiesterase 4 inhibitors in children with mild-to-moderate atopic dermatitis: A systematic review and meta-analysis.The Journal of international medical research · 2025Pooled it
- Pooled it
- Visualization of childhood allergic diseases based on VOSviewer and CiteSpace.Frontiers in medicine · 2025Pooled it
- Emerging trends and research hotspots in atopic dermatitis-related itch over the past 10 years: a bibliometric and visual analysis.Frontiers in medicine · 2025Pooled it
- Topical anti-inflammatory treatments for eczema: network meta-analysis.The Cochrane database of systematic reviews · 2024Pooled it
- Systemic Therapy for Atopic Dermatitis in Children and Adolescents: A US Expert Consensus.Dermatology (Basel, Switzerland) · 2024Guideline
- Skin care interventions in infants for preventing eczema and food allergy.The Cochrane database of systematic reviews · 2022Pooled it
- Anti-IL-4Rα antibody SHR-1819 for moderate-to-severe atopic dermatitis: a randomized phase 2 study.BMC medicine · 2026Trial
- A randomized controlled phase Ia clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of tofacitinib tartrate cream (HZ-J001) in healthy Chinese subjects.Frontiers in pharmacology · 2026Trial
- Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis.Acta dermato-venereologica · 2024Trial
- Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies.American journal of clinical dermatology · 2024Trial
- Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2023Trial
- Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study.The British journal of dermatology · 2022Trial
- Monoclonal Antibodies in Pediatric Atopic Dermatitis; Efficacy and Safety.Current therapeutic research, clinical and experimental · 2026Review
- Atopic dermatitis management: integrating disease mechanisms with precision medicine and nanotechnology-based targeted therapies.Irish journal of medical science · 2026Review
- Review
- Clinical Dose-Response of Inflammation Formula Number 1 Granules Versus Traditional Decoction in the Treatment of Patients With Mild to Moderate Atopic Dermatitis: Protocol for a Multicenter Randomized Controlled Trial.JMIR research protocols · 2026Article
365 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
23 authors at 17 institutions in 4 countries.
Lawrence F EichenfieldDivision of Pediatric and Adolescent Dermatology, University of California, San Diego, California; Rady Children's Hospital, San Diego, California.
Wynnis L TomDivision of Pediatric and Adolescent Dermatology, University of California, San Diego, California; Rady Children's Hospital, San Diego, California.
Timothy G BergerDepartment of Dermatology, University of California, San Francisco, California.
Alfons KrolDepartment of Dermatology, Oregon Health and Science University, Portland, Oregon.
Amy S PallerDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Kathryn SchwarzenbergerKaplan-Amonette Department of Dermatology, University of Tennessee Health Science Center, Memphis, Tennessee.
James N BergmanDepartment of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
Sarah L ChamlinDepartment of Dermatology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
David E CohenRonald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
Kevin D CooperDepartment of Dermatology, Case Western University, Cleveland, Ohio.
Kelly M CordoroDepartment of Dermatology, University of California, San Francisco, California.
Dawn M DavisDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota.
Steven R FeldmanDepartment of Dermatology, Wake Forest University Health Sciences, Winston-Salem, North Carolina.
Jon M HanifinDepartment of Dermatology, Oregon Health and Science University, Portland, Oregon.
David J MargolisDepartment of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
Robert A Silvermanprivate practice, Fairfax, Virginia.
Eric L SimpsonDepartment of Dermatology, Oregon Health and Science University, Portland, Oregon.
Hywel C WilliamsCenter of Evidence-based Dermatology, Nottingham University Hospitals National Health Service Trust, Nottingham, United Kingdom.
Craig A ElmetsDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama.
Julie BlockNational Eczema Association, San Rafael, California.
Christopher G HarrodAmerican Academy of Dermatology, Schaumburg, Illinois.
Wendy Smith BegolkaAmerican Academy of Dermatology, Schaumburg, Illinois. Electronic address: wsmithbegolka@aad.org.
Robert SidburyDepartment of Dermatology, Seattle Children's Hospital, Seattle, Washington.
Oregon Health & Science University · USAmerican Academy of Dermatology · USUniversity of California San Diego · USUniversity of California, San Francisco · USLurie Children's Hospital · USMayo Clinic · USNational Eczema Association · USNational Health Service · GBNew York University · USNorthwestern University · USSeattle Children's Hospital · USUniversity of Alabama at Birmingham · USUniversity of British Columbia · CAUniversity of Pennsylvania · USUniversity of Tennessee Health Science Center · USWake Forest University · USWestern University of Health Sciences · US
Funding
Vitamin D endocrine system and Protection Against Skin TumorlgenesisP30AR039750 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI COOPER, KEVIN D · 1988 to 2015
$9.1MGenetic Influence in Pediatric PsoriasisK23AR060274 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TOM, WYNNIS L · 2011 to 2015
$663kNIAMS NIH HHS K23 AR060274NIAMS NIH HHS K23AR060274NIAMS NIH HHS P30 AR039750
Abstract
Atopic dermatitis is a common and chronic, pruritic inflammatory skin condition that can affect all age groups. This evidence-based guideline addresses important clinical questions that arise in its management. In this second of 4 sections, treatment of atopic dermatitis with nonpharmacologic interventions and pharmacologic topical therapies are reviewed. Where possible, suggestions on dosing and monitoring are given based on available evidence.
Indexed as
Calcineurin InhibitorsPractice Guidelines as TopicAdministration, TopicalAdrenal Cortex HormonesChronic DiseaseDermatitis, AtopicEmollientsEvidence-Based MedicineHistamine AntagonistsHumansAdrenal Cortex HormonesCalcineurin InhibitorsEmollientsHistamine Antagonistsantihistaminesantimicrobialsatopic dermatitisbathingcalcineurin inhibitorscorticosteroidsemollientstopicalswet wraps
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
NCT02763722ClinicalTrials.gov
NCT02864498ClinicalTrials.gov
NCT03775590ClinicalTrials.gov
NCT03832010ClinicalTrials.gov
NCT06980961ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.